Clinical Trials Logo

Clinical Trial Summary

Non-Invasive ventilation (NIV) is a life saving intervention for patients with acute respiratory failure (ARF). Some patients are not able to tolerate the NIV intervention and ultimately fail, requiring the use of invasive mechanical ventilation (IMV) and intubation. Sedation may improve a patient's NIV tolerance. However, this practice has not been adopted by intensivists as the risk of over-sedation resulting in respiratory depression, inability to protect the airway, and inadvertent need for intubation are all large deterrents of sedative use in NIV. The Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults: a Pragmatic Randomized Controlled Trial (inDEX) is looking to evaluate the effectiveness of dexmedetomidine compared to placebo in reducing non-invasive ventilation failures in patients admitted to the hospital with acute respiratory failure.


Clinical Trial Description

Acute respiratory failure (ARF) is a common reason for admission to an intensive care unit (ICU). Non-invasive positive pressure ventilation (NIV) is a life-saving intervention for selected patients with ARF. Compared to endotracheal intubation and invasive mechanical ventilation (IMV), NIV is safer, less invasive, preferred by most patients, and is associated with a reduced ICU length of stay (LOS), less pneumonia and mortality, and lower healthcare costs. NIV failure can occur, necessitating IMV. Risk factors associated with NIV failure including intolerance, agitation, and delirium. Sedation is a potential solution for NIV intolerance, however the evidence is sparse and the risk of over-sedation resulting in respiratory depression, inability to protect the airway, and inadvertent need for intubation are all large deterrents. Dexmedetomidine (Dex) is an α2-adrenergic agonist sedative commonly used in IMV that promotes patient wakefulness, has no effect on respiratory drive, has important analgesic properties, and reduces delirium. The investigators hypothesize that Dex, when compared to placebo, reduces NIV failure in hospitalized adults with ARF and agitation or NIV intolerance. Overall Goal: To determine if Dex, compared to placebo, reduces the risk of NIV failure in patients that admitted to hospital with acute respiratory failure and are intolerant of NIV. Target Population: 826 patients will be enrolled into the vanguard trial if they meet all the following criteria: 1) ≥18 years old; 2) Receiving any NIV modality for ARF of any etiology; 3) Admitted to ICU, PACU, step-down unit (surgical or medical), or emergency department; 4) Presence of one or more of the following: a) Agitation, b) Patient expresses intolerance or requests removal of NIV secondary to self-reported discomfort, anxiety, or claustrophobia, or c) Other reason that the physician feels the patient is intolerant of NIV or agitated, not captured above. Methods: The inDEX trial is a pragmatic, international, multi-centred, stratified, randomized, parallel-group, placebo-controlled trial. Patients, investigators, healthcare team, data collectors, outcome assessors, and the statistician will be blinded to trial arms. The trial will maximize external validity by including patients in a range of hospitals across the world. Patients randomized to the experimental arm will receive Dex while those randomized to the control arm will receive placebo. Assessment: The primary outcome is NIV failure. The investigators define NIV failure as the proportion that require intubation or have died at 28 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06259565
Study type Interventional
Source St. Joseph's Healthcare Hamilton
Contact Kimberley Lewis, MD
Phone (289)775-7334
Email kimberley.lewis@medportal.ca
Status Not yet recruiting
Phase Phase 3
Start date October 2, 2024
Completion date January 2, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05756387 - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Completed NCT02973373 - MRI of the Chest Under High Frequency Ventilation N/A
Recruiting NCT06072339 - Optimization of Positive End Expiratory Pressure by Use of Pulmonary Ultrasound for Patients With Blunt Chest Trauma Treated by Non-Invasive Ventilation (Opti-PEP). N/A
Recruiting NCT04054622 - Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
Completed NCT03859947 - High-flow Nasal Cannula Flow Rates, Severe Bronchiolitis
Completed NCT03149835 - NIV Reduces CBF in COPD Patients Without Cognitive Function N/A
Recruiting NCT04036175 - Comparison of Patient Work of Breathing and Tidal Volumes With High Flow Nasal Cannula Oxygen Therapy and NIV (Non-Invasive Ventilation) After Extubation in the ICU. N/A
Recruiting NCT02712190 - Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation. N/A
Not yet recruiting NCT05435183 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving Carbon Dioxide Clearance in AECOPD Patients N/A
Recruiting NCT05796297 - Clinical Impact of Patient-ventilator Asynchrony
Not yet recruiting NCT05850195 - Assessment Of Different Indices in Prediction of Noninvasive Ventilation Failure in Patients With Acute Respiratory Failure
Not yet recruiting NCT05448417 - Exploration of Non-invasive High-frequency Oscillations in Human-machine Asynchrony in Healthy Subjects N/A
Completed NCT05031650 - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room N/A
Completed NCT03130361 - Wearable Noninvasive Positive Pressure Ventilation Device in COPD N/A
Completed NCT04178694 - The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers N/A
Not yet recruiting NCT05721833 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving CO2 Clearance in COPD Patients N/A
Not yet recruiting NCT05706467 - The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia N/A
Recruiting NCT01961245 - Effects of Nocturnal Non-invasive Ventilation on Energy Expenditure in Patients With Severe Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03978221 - Tissue Doppler Ultrasound During Spontaneous Breathing and Non-invasive Ventilation in the Post-extubation Period. N/A
Completed NCT04884828 - Asynchronies in NIV With External Gas